SOCS2 and metabolic dysfunction-associated steatohepatitis: NASH model showed that SOCS2 overexpression alleviates the development of NASH compared with the controls, as evidence by a reduced whole body, increased hepatocyte vacuolation, steatosis, and fibrosis (Figure 5B, C).